133 related articles for article (PubMed ID: 18804762)
1. Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT).
Saremi A; Anderson RJ; Luo P; Moritz TE; Schwenke DC; Allison M; Reaven PD;
Atherosclerosis; 2009 Apr; 203(2):610-4. PubMed ID: 18804762
[TBL] [Abstract][Full Text] [Related]
2. Rates and determinants of coronary and abdominal aortic artery calcium progression in the Veterans Affairs Diabetes Trial (VADT).
Saremi A; Moritz TE; Anderson RJ; Abraira C; Duckworth WC; Reaven PD;
Diabetes Care; 2010 Dec; 33(12):2642-7. PubMed ID: 20807873
[TBL] [Abstract][Full Text] [Related]
3. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
4. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
5. Association of lipoprotein-associated phospholipase A2 mass and activity with coronary and aortic atherosclerosis: findings from the Dallas Heart Study.
Brilakis ES; Khera A; Saeed B; Banerjee S; McGuire DK; Murphy SA; de Lemos JA
Clin Chem; 2008 Dec; 54(12):1975-81. PubMed ID: 18832472
[TBL] [Abstract][Full Text] [Related]
6. HDL-C levels modify the association between C-reactive protein and coronary artery calcium score.
Sung KC; Cho EJ; Lim YH; Shin J; Pyun WB; Kang SM; Rosenson RS
Nutr Metab Cardiovasc Dis; 2014 Nov; 24(11):1240-5. PubMed ID: 25096924
[TBL] [Abstract][Full Text] [Related]
7. Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses.
Shi Y; Zhang P; Zhang L; Osman H; Mohler ER; Macphee C; Zalewski A; Postle A; Wilensky RL
Atherosclerosis; 2007 Mar; 191(1):54-62. PubMed ID: 16765356
[TBL] [Abstract][Full Text] [Related]
8. Higher lipoprotein-associated phospholipase A2 levels are associated with coronary atherosclerosis documented by coronary angiography.
Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Thuboi S; Ogita M; Miyazaki T; Nishino A; Yokoyama K; Kurata T; Yatomi Y; Daida H
Ann Clin Biochem; 2012 Nov; 49(Pt 6):527-33. PubMed ID: 22933444
[TBL] [Abstract][Full Text] [Related]
9. Association between the lipoprotein-associated phospholipase A2 activity and the progression of subclinical atherosclerosis.
Liu J; Wang W; Qi Y; Yong Q; Zhou G; Wang M; Sun J; Liu J; Jia Z; Zhao D
J Atheroscler Thromb; 2014; 21(6):532-42. PubMed ID: 24492522
[TBL] [Abstract][Full Text] [Related]
10. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease.
Ikonomidis I; Kadoglou NN; Tritakis V; Paraskevaidis I; Dimas K; Trivilou P; Papadakis I; Tzortzis S; Triantafyllidi H; Parissis J; Anastasiou-Nana M; Lekakis J
Atherosclerosis; 2014 May; 234(1):34-41. PubMed ID: 24594367
[TBL] [Abstract][Full Text] [Related]
11. Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis.
Reaven PD; Moritz TE; Schwenke DC; Anderson RJ; Criqui M; Detrano R; Emanuele N; Kayshap M; Marks J; Mudaliar S; Harsha Rao R; Shah JH; Goldman S; Reda DJ; McCarren M; Abraira C; Duckworth W;
Diabetes; 2009 Nov; 58(11):2642-8. PubMed ID: 19651816
[TBL] [Abstract][Full Text] [Related]
12. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
[TBL] [Abstract][Full Text] [Related]
13. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A(2) in patients with stable angina.
Gajos G; Zalewski J; Mostowik M; Konduracka E; Nessler J; Undas A
Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):434-9. PubMed ID: 24555913
[TBL] [Abstract][Full Text] [Related]
14. [Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors].
Acevedo M; Varleta P; Kramer V; Quiroga T; Prieto C; Parada J; Adasme M; Briones L; Navarrete C
Rev Med Chil; 2013 Nov; 141(11):1382-8. PubMed ID: 24718463
[TBL] [Abstract][Full Text] [Related]
15. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.
Lavi S; McConnell JP; Rihal CS; Prasad A; Mathew V; Lerman LO; Lerman A
Circulation; 2007 May; 115(21):2715-21. PubMed ID: 17502572
[TBL] [Abstract][Full Text] [Related]
16. Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation.
Erbel R; Möhlenkamp S; Lehmann N; Schmermund A; Moebus S; Stang A; Grönemeyer D; Seibel R; Mann K; Volbracht L; Dragano N; Siegrist J; Jöckel KH;
Atherosclerosis; 2008 Apr; 197(2):662-72. PubMed ID: 17386928
[TBL] [Abstract][Full Text] [Related]
17. Association of systemic inflammation with epicardial fat and coronary artery calcification.
Gauss S; Klinghammer L; Steinhoff A; Raaz-Schrauder D; Marwan M; Achenbach S; Garlichs CD
Inflamm Res; 2015 May; 64(5):313-9. PubMed ID: 25763815
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-associated phospholipase A2 and coronary calcification. The Rotterdam Coronary Calcification Study.
Kardys I; Oei HH; Hofman A; Oudkerk M; Witteman JC
Atherosclerosis; 2007 Apr; 191(2):377-83. PubMed ID: 16678183
[TBL] [Abstract][Full Text] [Related]
19. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
[TBL] [Abstract][Full Text] [Related]
20. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis.
Stompór T; Pasowicz M; Sulłowicz W; Dembińska-Kieć A; Janda K; Wójcik K; Tracz W; Zdzienicka A; Klimeczek P; Janusz-Grzybowska E
Am J Kidney Dis; 2003 Jan; 41(1):203-11. PubMed ID: 12500238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
